Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00348621 · ClinicalTrials.gov registry record · Phase 4
A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents
A Phase 4 study of Cataract and Low Vision, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 4
- Development phase
- 2,544
- Enrollment target
- 1
- Study location
NCT00348621 is a Phase 4 study of Cataract and Low Vision that has completed, run by Johns Hopkins University. The registered enrollment target is 2,544 participants, above the 198-participant average among 83 other Cataract trials with a reported enrollment target (1185% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00348621, a Phase 4 study of Cataract and Low Vision, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 2,544 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to determine if interventions within the nursing home to restore vision, or cope with visual loss, in residents with visual impairment result in improvement or less decline in mobility scores, and socialization scores, compared to residents with visual impairment in nursing homes with no such intervention. The investigators hypothesized that nursing home residents with visual loss who receive cataract surgery, or refractive correction, or low vision aids would have have better socialization scores and mobility scores at 6 months and 12 months compared to nursing home residents with visual impairment who are advised to seek services, but have no specific program.
Conditions Studied
Interventions
- PROCEDURE Visual impairment intervention program
Study Locations (1)
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,544 participants |
| Start Date | 1999-06 |
| Est. Completion | 2002-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00348621
The ClinicalTrials.gov registry entry for NCT00348621 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 2,544 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 198-participant average among 83 other Cataract trials with a reported enrollment target (1185% higher). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Visual impairment intervention program is the first listed.
NCT00348621 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00348621 about?
NCT00348621 is a clinical study titled "A Study of Interventions to Reduce Disability From Visual Loss in Nursing Home Residents". The purpose of this clinical trial is to determine if interventions within the nursing home to restore vision, or cope with visual loss, in residents with visual impairment result in improvement or less decline in mobility scores, and socialization scores, compared to residents with visual impairmen...
What is the current status of trial NCT00348621?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 2,544 participants. The study started on 1999-06. Estimated completion is 2002-06.
What conditions does trial NCT00348621 study?
This clinical trial studies the following conditions: Cataract, Low Vision, Refractive Error.
What interventions are being tested in trial NCT00348621?
The interventions under investigation include: Visual impairment intervention program (PROCEDURE).
Who is sponsoring clinical trial NCT00348621?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00348621 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.